.: Home > DSRTF News > About DSRTF’s Scientific Advisory Board
News and Events :: DSRTF News
About DSRTF’s Scientific Advisory Board
January 2007
As a private nonprofit foundation, a major goal for DSRTF is to re-energize research and exploration of the neurobiological basis for cognitive disability in both children and adults with Down syndrome and the pursuit of studies that will accelerate translation of discovery and delivery of effective treatments. The DSRTF believes that the recent advances in biomedical research and technologies provide an unprecedented opportunity to significantly impact research into the mechanisms of cognitive dysfunction associated with this complex genetic disorder and new therapeutic interventions. The principal means for advancing DSRTF goals includes spearheading new ideas and approaches as well as increasing knowledge, awareness, and interest within the scientific biomedical research community and funding of innovative and rigorous research. Key to achieving these goals is the establishment of the DSRTF Scientific Advisory Board to provide critical perspective, advice, and recommendations to the DSRTF Board of Directors.
Comprising nationally and internationally recognized scientists and clinicians pursuing research in the field of Down syndrome neurobiology and related fields, clinician-researchers with expertise in Down syndrome or in related clinical areas, industry scientific representatives with expertise in the translation and application of research advances, and scientists who possess a broad and innovative research perspective and unique expertise potentially relevant to Down syndrome, it is intended that the Scientific Advisory Board will create a unique interactive, challenging, and collegial scientific leadership opportunity for this highly imaginative, critical, and independent network of advisors.
Scientific Advisory Board
| |
William Cohen, M.D.
Children’s Hospital of Pittsburgh
Child Development Unit
Pittsburgh, Pennsylvania
David Cox, M.D., Ph.D.
Perlegen Sciences, Incorporation
Mountain View, California
Ronald Evans, Ph.D.
Salk Institute for Biological Studies
Howard Hughes Medical Institute
La Jolla, California
Michael M. Harpold, Ph.D.
EnkephaSys, Incorporation
Tucson, Arizona |
Eric Kandel, M.D.
Columbia University of Physicians & Surgeons
Howard Hughes Institute in Molecular
Neurobiology & Behavior
New York, New York
Leslie Leinwand, Ph.D.
University of Colorado
Boulder, Colorado
Lynn Nadel, Ph.D.
University of Arizona
Department of Psychology
Tucson, Arizona
Roger Reeves, Ph.D.
Johns Hopkins School of Medicine
McKusick-Nathans Institute for Genetic Medicine
Baltimore, Maryland |
|
|